Generating Double-Crossover Recombinants of Pseudomonas aeruginosa for Targeted Gene Deletion
JoVE Encyclopedia of Experiments
Microbiology
0 views • 2:27 min • September 26th, 2025
Loading...
Overview
This article describes a method for generating double crossover recombinants in Pseudomonas aeruginosa using a non-replicative plasmid. The process involves antibiotic selection and sucrose sensitivity to confirm successful genetic modifications.
Key Study Components
Area of Science
- Microbiology
- Genetic Engineering
- Antibiotic Resistance
Background
- Pseudomonas aeruginosa is a model organism for studying genetic manipulation.
- Homologous recombination is a key technique for gene deletion.
- Antibiotic resistance genes are often used as selection markers.
- Sucrose sensitivity can be utilized to identify successful recombinants.
Purpose of Study
- To develop a reliable method for creating double crossover recombinants in Pseudomonas aeruginosa.
- To utilize antibiotic resistance and sucrose sensitivity for selection.
- To confirm genetic modifications through growth assays.
Methods Used
- Culture of recombinant Pseudomonas aeruginosa in antibiotic selection medium.
- Integration of a non-replicative plasmid into the bacterial genome.
- Streaking bacteria on sucrose medium to induce double crossover.
- Growth assays on selective and non-selective media to confirm recombinants.
Main Results
- Successful excision of the plasmid and target gene confirmed by growth patterns.
- Double crossover recombinants exhibited sucrose resistance and antibiotic sensitivity.
- Colony growth on selective media validated the genetic modifications.
Conclusions
- The method effectively generates double crossover recombinants in Pseudomonas aeruginosa.
- Antibiotic resistance and sucrose sensitivity are reliable markers for selection.
- This approach can be applied to other genetic engineering studies in bacteria.
Frequently Asked Questions
What is the significance of double crossover recombination?
Double crossover recombination allows for precise gene deletions in bacterial genomes, facilitating genetic studies.
How does sucrose sensitivity aid in selection?
Sucrose sensitivity helps identify successful recombinants by allowing only those that have undergone the desired genetic modification to grow.
What role does the antibiotic resistance gene play?
The antibiotic resistance gene serves as a selection marker, ensuring that only bacteria that have integrated the plasmid are initially cultured.
Can this method be applied to other bacterial species?
While this method is optimized for Pseudomonas aeruginosa, similar techniques can be adapted for other bacterial species with appropriate modifications.
What are the potential applications of this genetic engineering technique?
This technique can be used in research to study gene function, develop new antibiotic resistance models, and explore metabolic pathways in bacteria.
How long does the entire process take?
The process can take several days, including culture growth, selection, and confirmation of recombinants.
Executive Industry Relevance
This method enables precise genetic manipulation in Pseudomonas aeruginosa, a key model for studying virulence and antibiotic resistance. By generating in-frame gene deletions, researchers can de-risk target validation and assess therapeutic hypotheses with greater predictive confidence. The approach supports early discovery workflows where mechanistic clarity is essential for portfolio prioritization.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses through targeted gene deletion in a clinically relevant pathogen.
- Operational Value: Provides a reproducible system for functional validation of virulence factors and resistance mechanisms.
- Strategic Value: Supports predictive confidence in target selection by confirming phenotypic outcomes of genetic modification.
Screening & Assay Development
- Scientific Value: Generates isogenic mutant strains suitable for standardized phenotypic screening assays.
- Operational Value: Ensures genetic consistency across replicates, reducing variability in compound screening outcomes.
- Strategic Value: Facilitates assay readiness by providing well-characterized biological systems for downstream evaluation.
Translational & Preclinical Research
- Scientific Value: Enables mechanistic de-risking by linking genotype to virulence attenuation in infection models.
- Operational Value: Supports translational continuity from genetic modification to phenotypic assessment in vivo.
- Strategic Value: Informs risk-adjusted advancement decisions by validating target essentiality in disease-relevant systems.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target validation to preclinical evaluation, enabling iterative design-build-test cycles for antimicrobial target identification.
- Discovery Biology: Supports hypothesis testing and pathway clarification through precise genetic excision of target loci.
- Screening: Delivers assay-ready mutant strains with confirmed genotypes for reliable compound or condition screening.
- Analytics: Provides quantitative growth-based readouts (sucrose resistance, antibiotic sensitivity) to confirm genetic modifications.
- Translational Research: Connects genetic manipulation to phenotypic outcomes in infection models, supporting biomarker-aligned target validation.
- Enterprise Reuse: Establishes a reusable genetic engineering platform applicable across multiple targets in Pseudomonas aeruginosa.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in target function, reduction of mechanistic ambiguity in virulence pathways.
- Operational Value: Standardization, reproducibility, and scalability of mutant strain generation.
- Strategic Value: Improved go/no-go decisions, capital efficiency, and reduced late-stage biological risk in antimicrobial programs.
- Portfolio Impact: Risk-adjusted prioritization of targets based on validated genetic and phenotypic data.
Implementation Considerations
- Requires expertise in bacterial genetics and homologous recombination techniques.
- Dependent on plasmid construction, antibiotic selection, and sucrose counter-selection infrastructure.
- Needs cross-team standardization for strain handling, genotyping, and phenotypic confirmation.
- Adaptation considerations include efficiency of homologous recombination across different genomic loci.
- Practical limitations include potential for single-crossover events requiring careful screening to isolate true double-crossover recombinants.
Biopharma FAQs
Why does loss of antibiotic resistance confirm double crossover?
Loss of antibiotic resistance indicates excision of the plasmid-borne resistance gene, which only occurs after a second recombination event. This serves as a key diagnostic output for confirming successful gene deletion.
How does sucrose selection enable isolation of recombinants?
Sucrose selection leverages the sacB gene, which confers sensitivity; only bacteria that have excised the plasmid survive, enabling enrichment of double-crossover events.
What quantitative growth measurements validate recombinant success?
Growth on sucrose-containing media and absence of growth on antibiotic media provide binary, quantifiable outcomes used to confirm double-crossover recombination.
Why are replication steps critical for confirming genetic modification?
Replication across selective and non-selective media ensures phenotypic consistency, reducing false positives and supporting reliable data sharing between discovery and preclinical teams.
What statistical thresholds are used to distinguish true recombinants?
True double-crossover recombinants are identified by 100% concordance: sucrose resistance and antibiotic sensitivity across replicated patches, ensuring high-confidence validation.
07:18
Gene-targeted Random Mutagenesis to Select Heterochromatin-destabilizing Proteasome Mutants in Fission Yeast
Related Videos
0 Views
08:13
Producing Gene Deletions in Escherichia coli by P1 Transduction with Excisable Antibiotic Resistance Cassettes
Related Videos
0 Views
12:29
Generation of Null Mutants to Elucidate the Role of Bacterial Glycosyltransferases in Bacterial Motility
Related Videos
0 Views
14:06
Mapping Bacterial Functional Networks and Pathways in Escherichia Coli using Synthetic Genetic Arrays
Related Videos
0 Views
04:14
Generation of Antibiotic-Marked Mutants in Cyanobacteria via Homologous Recombination
Related Videos
0 Views
03:36
Generating Gene Deletions in E. coli via Phage-Mediated Transfer of an Excisable Antibiotic Cassette
Related Videos
0 Views
09:52
Genetic Manipulation in Δku80 Strains for Functional Genomic Analysis of Toxoplasma gondii
Related Videos
0 Views
08:57
Identification of Novel Genes Associated with Alginate Production in Pseudomonas aeruginosa Using Mini-himar1 Mariner Transposon-mediated Mutagenesis
Related Videos
0 Views
09:40
Generation of Genomic Deletions in Mammalian Cell Lines via CRISPR/Cas9
Related Videos
0 Views
10:10
Genetic Engineering of an Unconventional Yeast for Renewable Biofuel and Biochemical Production
Related Videos
0 Views
Last updated: 11 July 2026